261 related articles for article (PubMed ID: 31345185)
21. Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.
Jiang GY; Zhang XP; Zhang Y; Xu HT; Wang L; Li QC; Wang EH
Hum Pathol; 2016 Oct; 56():64-73. PubMed ID: 27342910
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
24. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
[TBL] [Abstract][Full Text] [Related]
25. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
[TBL] [Abstract][Full Text] [Related]
26. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
Chang JH; Cheng CW; Yang YC; Chen WS; Hung WY; Chow JM; Chen PS; Hsiao M; Lee WJ; Chien MH
J Exp Clin Cancer Res; 2018 Aug; 37(1):199. PubMed ID: 30134935
[TBL] [Abstract][Full Text] [Related]
27. The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation.
Kang X; Li P; Zhang C; Zhao Y; Hu H; Wen G
Int J Oncol; 2020 Aug; 57(2):456-465. PubMed ID: 32468028
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
30. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
31. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells.
Gao L; Yang T; Zhang S; Liang Y; Shi P; Ren H; Hou P; Chen M
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907840
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
34. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
35. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway.
Li J; Li Y; Wang B; Ma Y; Chen P
J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161
[TBL] [Abstract][Full Text] [Related]
36. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer].
Zhao X; Tuo H; Si M; Wang L; Liang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304
[TBL] [Abstract][Full Text] [Related]
37. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
38. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z
Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376
[TBL] [Abstract][Full Text] [Related]
39. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
40. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
